- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
CD20 antibody recognizes CD20, also known as Membrane spanning 4-domains subfamily A member 1, a B-cell specific transmembrane phosphoprotein encoded by the MS4A1 gene. CD20 is localized to the plasma membrane of B lymphocytes, where it regulates B-cell activation, proliferation, and calcium signaling. CD20 Antibody for IHC is optimized for detecting CD20 expression in formalin-fixed, paraffin-embedded tissues for research applications focused on lymphoma biology and immune cell profiling.
The MS4A1 gene is located on chromosome 11q12.2 and encodes a protein characterized by four transmembrane domains with cytoplasmic N- and C-terminal regions. CD20 expression begins at the late pre-B-cell stage and continues through mature B cells but is absent on hematopoietic stem cells and terminally differentiated plasma cells. This lineage-restricted expression makes CD20 one of the most widely used markers for identifying B-cell populations in lymphoid tissues such as tonsil, lymph node, and spleen.
Functionally, CD20 associates with the B-cell receptor signaling complex and contributes to calcium influx following antigen stimulation. Although CD20 lacks a defined soluble ligand, it participates in membrane microdomains that regulate signal transduction and B-cell activation. Aberrant CD20 expression is characteristic of B-cell non-Hodgkin lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, and chronic lymphocytic leukemia. CD20 Antibody for IHC supports evaluation of CD20 distribution and density in both normal and malignant tissues.
Immunohistochemical detection of CD20 is widely used in research classification of lymphoid neoplasms and in studies investigating tumor microenvironment composition. Assessment of membranous CD20 staining patterns helps distinguish B-cell lineage from T-cell or non-lymphoid populations. Clone MS4A1/3411 is engineered to provide consistent performance and clear membranous staining in tissue sections.
By targeting a well-established B-cell surface antigen, CD20 Antibody for IHC provides a reliable tool for examining B-cell localization, lymphoma pathology, and immune architecture in research settings.
The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the CD20 antibody to be titered up or down for optimal performance.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
Amino acids 213-297 from the human protein were used as the immunogen for this CD20 antibody.
CD20 antibody with azide can be stored at 2-8oC. The azide-free format should be aliquoted and stored at -20oC or colder.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.